We're now accepting registrations on Spevigo (spesolimab) for patients with Generalised Pustular Psoriasis, and registrations on Sotyktu (deucravacitinib).
Live

Welcome to the BADBIR database

Welcome to the BADBIR Database

The University of Manchester Printed by anonymous on 19/04/2024. By printing this page, the user agrees to store this paper securely or destroy it immediately.